News

Academics should use their intellectual property to produce cheap drugs for poor countries

BMJ 2007; 334 doi: https://doi.org/10.1136/bmj.39220.628692.DB (Published 24 May 2007) Cite this as: BMJ 2007;334:1079
  1. Geoff Watts
  1. London

    It is time to stop leaving the development of new drugs entirely to the marketplace, say two London academics. Universities should not only retain control over their intellectual property but use it for long term social goals rather than short term revenue, they say.

    The physician Sunil Shaunak, of Imperial College London, and the chemist Steve Brocchini, of the School of Pharmacy, London, were speaking last week at a meeting of the House of Commons all-party pharmacy group.

    Most drugs begin their life at high prices and under patent. In due …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe